{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T02:27:11Z","timestamp":1776220031384,"version":"3.50.1"},"publisher-location":"New York, NY, USA","reference-count":289,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Cambridge Cambridge Biomedical Research Centre","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"UK Medical Research Council","award":["MC-UU-00002\/15"],"award-info":[{"award-number":["MC-UU-00002\/15"]}]},{"name":"EPSRC Prosperity Partnership between Microsoft Research and the University of Cambridge","award":["EP\/T005386\/1"],"award-info":[{"award-number":["EP\/T005386\/1"]}]},{"name":"EPSRC Turing AI Fellowship","award":["EP\/V025279\/1"],"award-info":[{"award-number":["EP\/V025279\/1"]}]}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,21]]},"DOI":"10.1145\/3531146.3533154","type":"proceedings-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T14:27:10Z","timestamp":1655735230000},"page":"906-924","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Multi-disciplinary fairness considerations in machine learning for clinical trials"],"prefix":"10.1145","author":[{"given":"Isabel","family":"Chien","sequence":"first","affiliation":[{"name":"Machine Learning Group, University of Cambridge, United Kingdom"}]},{"given":"Nina","family":"Deliu","sequence":"additional","affiliation":[{"name":"MRC Biostatistics Unit, University of Cambridge, United Kingdom and MEMOTEF Department, Sapienza University of Rome, Italy"}]},{"given":"Richard","family":"Turner","sequence":"additional","affiliation":[{"name":"Machine Learning Group, University of Cambridge, United Kingdom"}]},{"given":"Adrian","family":"Weller","sequence":"additional","affiliation":[{"name":"Machine Learning Group, University of Cambridge, United Kingdom and The Alan Turing Institute, United Kingdom"}]},{"given":"Sofia","family":"Villar","sequence":"additional","affiliation":[{"name":"MRC Biostatistics Unit, University of Cambridge, United Kingdom"}]},{"given":"Niki","family":"Kilbertus","sequence":"additional","affiliation":[{"name":"Technical University of Munich, Germany and Helmholtz Munich, Germany"}]}],"member":"320","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"e_1_3_2_1_1_1","unstructured":"[n. d.]. Clinical trials regulations. https:\/\/www.ukri.org\/councils\/mrc\/guidance-for-applicants\/policies-and-guidance-for-researchers\/clinical-research-governance\/clinical-trials-regulations\/"},{"key":"e_1_3_2_1_2_1","unstructured":"[n. d.]. Ethics in clinical research. https:\/\/clinicalcenter.nih.gov\/recruit\/ethics.html"},{"key":"e_1_3_2_1_3_1","unstructured":"2021. How clinical trials are approved. https:\/\/www.cancerresearchuk.org\/about-cancer\/find-a-clinical-trial\/how-clinical-trials-are-planned-and-organised\/how-clinical-trials-are-approved"},{"key":"e_1_3_2_1_4_1","volume-title":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Vol.\u00a0172","author":"Abrahamyan Lusine","unstructured":"Lusine Abrahamyan, Brian\u00a0M Feldman, George Tomlinson, Marie\u00a0E Faughnan, Sindhu\u00a0R Johnson, Ivan\u00a0R Diamond, and Samir Gupta. 2016. Alternative designs for clinical trials in rare diseases. In American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Vol.\u00a0172. Wiley Online Library, 313\u2013331."},{"key":"e_1_3_2_1_5_1","volume-title":"Gender-sensitive word embeddings for healthcare. Journal of the American Medical Informatics Association : JAMIA","author":"Agmon Shunit","year":"2022","unstructured":"Shunit Agmon, Plia Gillis, Eric Horvitz, and Kira Radinsky. 2022. Gender-sensitive word embeddings for healthcare. Journal of the American Medical Informatics Association : JAMIA (2022)."},{"key":"e_1_3_2_1_6_1","volume-title":"Understanding randomised controlled trials. Archives of disease in childhood 90, 8","author":"Akobeng K","year":"2005","unstructured":"Al\u00a0K Akobeng. 2005. Understanding randomised controlled trials. Archives of disease in childhood 90, 8 (2005), 840\u2013844."},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Samina Ali Gareth Hopkin Naveen Poonai Lawrence Richer Maryna Yaskina Anna Heath Terry\u00a0P Klassen Christopher McCabe Amy Gareth Jeff Martin Petros Eleanor David Marie-Chri Drendel Hopkin Round Offringa\u00a0Pechlivanoglou Pulle Amy\u00a0L Drendel Gareth Hopkin Jeff Round Martin Offringa Petros Pechlivanoglou Eleanor\u00a0M. Pullenayegum David Rios Marie-Christine Auclair Kelly Kim Lise Bourrier Lauren\u00a0C. Dawson Kamary\u00a0Coriolano DaSilva Pamela Marples Rick Watts Jennifer Thull-Freedman Patrick\u00a0J. McGrath Timothy A.\u00a0D. Graham Lisa Hartling Tannis Erickson Brendon Foot Kurt Schreiner Julie Leung Martin Petros Eleanor Juan David Jeff Offringa Pechlivanoglou Pullenayegum\u00a0Rios Round and Juan\u00a0David Rios. 2021. A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences. Trials 22(2021).","DOI":"10.1186\/s13063-021-05164-1"},{"key":"e_1_3_2_1_8_1","volume-title":"Ordinal preference elicitation methods in health economics and health services research: using discrete choice experiments and ranking methods.British medical bulletin 103 1","author":"Ali Shehzad","year":"2012","unstructured":"Shehzad Ali and Sarah\u00a0J Ronaldson. 2012. Ordinal preference elicitation methods in health economics and health services research: using discrete choice experiments and ranking methods.British medical bulletin 103 1 (2012), 21\u201344."},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0034-3"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.2307\/1402871"},{"key":"e_1_3_2_1_11_1","volume-title":"Declaration of helsinki. Law, medicine & health care: a publication of the American Society of Law & Medicine 19, 3-4","author":"World\u00a0Medical Association 1991.","year":"1991","unstructured":"World\u00a0Medical Association 1991. Declaration of helsinki. Law, medicine & health care: a publication of the American Society of Law & Medicine 19, 3-4 (1991), 264\u2013265."},{"key":"e_1_3_2_1_12_1","unstructured":"Onur Atan William\u00a0R. Zame and Mihaela van\u00a0der Schaar. 2019. Sequential Patient Recruitment and Allocation for Adaptive Clinical Trials. In AISTATS."},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1510489113"},{"key":"e_1_3_2_1_14_1","volume-title":"Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.Journal of medical ethics 24, 6","author":"Avins L","year":"1998","unstructured":"Andrew\u00a0L Avins. 1998. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.Journal of medical ethics 24, 6 (1998), 401\u2013408."},{"key":"e_1_3_2_1_15_1","first-page":"1","article-title":"On Multi-Armed Bandit Designs for Dose-Finding Clinical Trials","volume":"22","author":"Aziz Maryam","year":"2021","unstructured":"Maryam Aziz, Emilie Kaufmann, and Marie-Karelle Riviere. 2021. On Multi-Armed Bandit Designs for Dose-Finding Clinical Trials. Journal of Machine Learning Research 22 (2021), 1\u201338.","journal-title":"Journal of Machine Learning Research"},{"key":"e_1_3_2_1_16_1","unstructured":"Jackie Baek and V. Farias. 2021. Fair Exploration via Axiomatic Bargaining. ArXiv abs\/2106.02553(2021)."},{"key":"e_1_3_2_1_17_1","unstructured":"Solon Barocas Moritz Hardt and A. Narayanan. 2018. Fairness and Machine Learning Limitations and Opportunities. In Fairness and Machine Learning."},{"key":"e_1_3_2_1_18_1","first-page":"671","article-title":"Big Data\u2019s Disparate Impact","volume":"104","author":"Barocas Solon","year":"2016","unstructured":"Solon Barocas and Andrew\u00a0D. Selbst. 2016. Big Data\u2019s Disparate Impact. California Law Review 104 (2016), 671.","journal-title":"California Law Review"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Hamsa Bastani and Mohsen Bayati. 2015. Online Decision-Making with High-Dimensional Covariates. Operations Research eJournal(2015).","DOI":"10.2139\/ssrn.2661896"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6472"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Fran\u00e7oise Baylis and Scott\u00a0A Halperin. 2012. Research involving pregnant women: trials and tribulations. Clinical investigation 2(2012) 139\u2013146.","DOI":"10.4155\/cli.11.178"},{"key":"e_1_3_2_1_22_1","unstructured":"Yahav Bechavod Christopher Jung and Zhiwei\u00a0Steven Wu. 2020. Metric-free individual fairness in online learning. arXiv preprint arXiv:2002.05474(2020)."},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"crossref","unstructured":"John\u00a0H. Beigel Kay\u00a0M Tomashek Lori\u00a0E. Dodd Aneesh\u00a0K. Mehta Barry\u00a0S. Zingman Andre\u00a0C. Kalil Elizabeth\u00a0L. Hohmann Helen\u00a0Y Chu Anne\u00a0F. Luetkemeyer Susan\u00a0E. Kline Diego\u00a0L\u00f3pez de Castilla Robert\u00a0W. Finberg Kerry\u00a0L. Dierberg Victor\u00a0F. Tapson Lanny Hsieh Thomas\u00a0F. Patterson Roger Paredes Daniel\u00a0A. Sweeney William\u00a0R. Short Giota Touloumi David Chien\u00a0Boon Lye Norio Ohmagari Myoung don Oh Guillermo Ruiz-Palacios Thomas\u00a0Lars Benfield Gerd F\u00e4tkenheuer Mark\u00a0G Kortepeter Robert\u00a0L. Atmar Clarence\u00a0Buddy Creech Jens\u00a0D. Lundgren Abdel\u00a0G. Babiker Sarah Pett James\u00a0D. Neaton Timothy\u00a0H. Burgess Tyler Bonnett Michelle\u00a0F. Green Mat Makowski Anu\u00a0O. Osinusi Seema\u00a0U. Nayak and Henry\u00a0Clifford Lane. 2020. Remdesivir for the Treatment of Covid-19 \u2014 Final Report. The New England Journal of Medicine(2020).","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz3873"},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510061"},{"key":"e_1_3_2_1_26_1","volume-title":"Proceedings of the 1st Conference on Fairness, Accountability and Transparency(Proceedings of Machine Learning Research, Vol.\u00a081)","author":"Binns Reuben","year":"2018","unstructured":"Reuben Binns. 2018. Fairness in Machine Learning: Lessons from Political Philosophy. In Proceedings of the 1st Conference on Fairness, Accountability and Transparency(Proceedings of Machine Learning Research, Vol.\u00a081), Sorelle\u00a0A. Friedler and Christo Wilson (Eds.). PMLR, 149\u2013159. https:\/\/proceedings.mlr.press\/v81\/binns18a.html"},{"key":"e_1_3_2_1_27_1","series-title":"Series B","volume-title":"Robust adaptive designs in clinical trials for continuous responses. Sankhy\u0101: The Indian Journal of Statistics","author":"Biswas Atanu","year":"2001","unstructured":"Atanu Biswas and Ayanendranath Basu. 2001. Robust adaptive designs in clinical trials for continuous responses. Sankhy\u0101: The Indian Journal of Statistics, Series B (2001), 27\u201342."},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Avrim Blum Jeffrey\u00a0C. Jackson Tuomas Sandholm and Martin\u00a0A. Zinkevich. 2003. Preference Elicitation and Query Learning. In J. Mach. Learn. Res.","DOI":"10.1007\/978-3-540-45167-9_3"},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Danielle\u00a0H Bodicoat Ash\u00a0C. Routen Andrew Willis Winifred Ekezie Clare\u00a0L Gillies Claire\u00a0Alexandra Lawson Thomas Yates Francesco Zaccardi Melanie\u00a0Jane Davies and Kamlesh Khunti. 2021. Promoting inclusion in clinical trials\u2014a rapid review of the literature and recommendations for action. Trials 22(2021).","DOI":"10.1186\/s13063-021-05849-7"},{"key":"e_1_3_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hast.783"},{"key":"e_1_3_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2005.035261"},{"key":"e_1_3_2_1_32_1","volume-title":"Unrepresentative big surveys significantly overestimated US vaccine uptake. Nature","author":"Bradley C","year":"2021","unstructured":"Valerie\u00a0C Bradley, Shiro Kuriwaki, Michael Isakov, Dino Sejdinovic, Xiao-Li Meng, and Seth Flaxman. 2021. Unrepresentative big surveys significantly overestimated US vaccine uptake. Nature (2021), 1\u20136."},{"key":"e_1_3_2_1_33_1","volume-title":"The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.The Journal of the American College of Dentists 81 3","author":"Brady V.","year":"2014","unstructured":"Joseph\u00a0V. Brady and Albert\u00a0R. Jonsen. 2014. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.The Journal of the American College of Dentists 81 3 (2014), 4\u201313."},{"key":"e_1_3_2_1_34_1","volume-title":"Guido van\u00a0der Groen, and Karl\u00a0M. Johnson","author":"Breman G.","year":"2016","unstructured":"Joel\u00a0G. Breman, David\u00a0L. Heymann, Graham Lloyd, Joseph\u00a0B. McCormick, M Miatudila, Frederick\u00a0A. Murphy, Jean-Jacques Muyembe-Tamfun, Peter Piot, J\u00a0F Ruppol, Pierre Sureau, Guido van\u00a0der Groen, and Karl\u00a0M. Johnson. 2016. Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.The Journal of infectious diseases 214 suppl 3 (2016), S93\u2013S101."},{"key":"e_1_3_2_1_35_1","volume-title":"Patient preferences and randomised clinical trials.British Medical Journal 299","author":"Brewin CR","year":"1989","unstructured":"CR Brewin and C Bradley. 1989. Patient preferences and randomised clinical trials.British Medical Journal 299 (1989), 313 \u2013 315."},{"key":"e_1_3_2_1_36_1","volume-title":"Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs. BMC medicine 18, 1","author":"Burnett Thomas","year":"2020","unstructured":"Thomas Burnett, Pavel Mozgunov, Philip Pallmann, Sofia\u00a0S Villar, Graham\u00a0M Wheeler, and Thomas Jaki. 2020. Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs. BMC medicine 18, 1 (2020), 1\u201321."},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1145\/3290605.3300234"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"crossref","unstructured":"D\u00a0Ross Camidge Haeseong Park Karen\u00a0E Smoyer Ira Jacobs Lauren\u00a0J Lee Zemfira Askerova Justin McGinnis and Yousef Zakharia. 2021. Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials. Future Oncology0(2021).","DOI":"10.2217\/fon-2020-1262"},{"key":"e_1_3_2_1_39_1","volume-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials.Annals of internal medicine 158 3","author":"Chan An-Wen","year":"2013","unstructured":"An-Wen Chan, Jennifer\u00a0Marie Tetzlaff, Douglas\u00a0G. Altman, Andreas Laupacis, Peter\u00a0Christian G\u00f8tzsche, Karmela Krleza-Jeric, Asbj\u00f8rn Hr\u00f5bjartsson, Howard Mann, Kay Dickersin, Jesse\u00a0A. Berlin, Caroline\u00a0J. Dor\u00e9, Wendy\u00a0R. Parulekar, William S\u00a0M Summerskill, Trish Groves, Kenneth\u00a0F. Schulz, Harold\u00a0C. Sox, Frank\u00a0W. Rockhold, Drummond Rennie, and David Moher. 2013. SPIRIT 2013 statement: defining standard protocol items for clinical trials.Annals of internal medicine 158 3 (2013), 200\u20137."},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"crossref","unstructured":"Danton Char N. Shah and D. Magnus. 2018. Implementing Machine Learning in Health Care - Addressing Ethical Challenges.The New England journal of medicine 378 11 (2018) 981\u2013983.","DOI":"10.1056\/NEJMp1714229"},{"key":"e_1_3_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jebo.2012.12.023"},{"key":"e_1_3_2_1_42_1","unstructured":"I. Chen Fredrik\u00a0D. Johansson and D. Sontag. 2018. Why Is My Classifier Discriminatory?. In NeurIPS."},{"key":"e_1_3_2_1_43_1","doi-asserted-by":"crossref","unstructured":"I. Chen E. Pierson Sherri Rose Shalmali Joshi Kadija Ferryman and M. Ghassemi. 2021. Ethical Machine Learning in Health Care. Annual review of biomedical data science 4 (2021) 123\u2013144.","DOI":"10.1146\/annurev-biodatasci-092820-114757"},{"key":"e_1_3_2_1_44_1","doi-asserted-by":"crossref","unstructured":"I. Chen Peter Szolovits and M. Ghassemi. 2019. Can AI Help Reduce Disparities in General Medical and Mental Health Care?AMA journal of ethics 21 2 (2019) E167\u2013179.","DOI":"10.1001\/amajethics.2019.167"},{"key":"e_1_3_2_1_45_1","unstructured":"Li Chen and Pearl Pu. 2004. Survey of Preference Elicitation Methods."},{"key":"e_1_3_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28575"},{"key":"e_1_3_2_1_47_1","unstructured":"Yifang Chen Alex Cuellar Haipeng Luo Jignesh Modi Heramb Nemlekar and S. Nikolaidis. 2020. Fair Contextual Multi-Armed Bandits: Theory and Experiments. In UAI."},{"key":"e_1_3_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.022"},{"key":"e_1_3_2_1_49_1","doi-asserted-by":"crossref","unstructured":"A. Chouldechova. 2017. Fair prediction with disparate impact: A study of bias in recidivism prediction instruments. Big data 5 2(2017) 153\u2013163.","DOI":"10.1089\/big.2016.0047"},{"key":"e_1_3_2_1_50_1","unstructured":"A. Chouldechova and Aaron Roth. 2018. The Frontiers of Fairness in Machine Learning. ArXiv abs\/1810.08810(2018)."},{"key":"e_1_3_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-11"},{"key":"e_1_3_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.1991.tb01817.x"},{"key":"e_1_3_2_1_53_1","volume-title":"Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.Current problems in cardiology 44 5","author":"Clark T","year":"2019","unstructured":"Luther\u00a0T Clark, Laurence Watkins, Ileana\u00a0L. Pi\u00f1a, Mary\u00a0E Elmer, Olakunle\u00a0O. Akinboboye, Millicent Gorham, Brenda\u00a0D. Jamerson, Cassandra McCullough, Christine Pierre, Adam\u00a0B. Polis, Gary\u00a0A. Puckrein, and Jeanne\u00a0M. Regnante. 2019. Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.Current problems in cardiology 44 5 (2019), 148\u2013172."},{"key":"e_1_3_2_1_54_1","doi-asserted-by":"crossref","unstructured":"John\u00a0A. Clithero Jae\u00a0Joon Lee and Joshua Tasoff. 2019. Supervised Machine Learning for Eliciting Individual Demand. Computational Materials Science eJournal(2019).","DOI":"10.2139\/ssrn.3380039"},{"key":"e_1_3_2_1_55_1","volume-title":"The Nuremberg Code. Trials of war criminals before the Nuremberg military tribunals under control council law 10","author":"Code Nuremberg","year":"1949","unstructured":"Nuremberg Code. 1949. The Nuremberg Code. Trials of war criminals before the Nuremberg military tribunals under control council law 10, 1949 (1949), 181\u20132."},{"key":"e_1_3_2_1_56_1","unstructured":"Office of\u00a0the Commissioner. [n. d.]. Step 3: Clinical research. https:\/\/www.fda.gov\/patients\/drug-development-process\/step-3-clinical-research"},{"key":"e_1_3_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"e_1_3_2_1_58_1","volume-title":"Corbett-Davies and Sharad Goel","author":"S.","year":"2018","unstructured":"S. Corbett-Davies and Sharad Goel. 2018. The Measure and Mismeasure of Fairness: A Critical Review of Fair Machine Learning. ArXiv abs\/1808.00023(2018)."},{"key":"e_1_3_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440080015003"},{"key":"e_1_3_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3259.ijct20160472"},{"key":"e_1_3_2_1_61_1","doi-asserted-by":"crossref","unstructured":"Ralph\u00a0B. D\u2019Agostino Scott\u00a0M. Grundy Lisa\u00a0M Sullivan and Pwf Wilson. 2001. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.JAMA 286 2(2001) 180\u20137.","DOI":"10.1001\/jama.286.2.180"},{"key":"e_1_3_2_1_62_1","volume-title":"A nonparametric updating method to correct clinical prediction model drift. Journal of the American Medical Informatics Association : JAMIA","author":"Davis E.","year":"2019","unstructured":"Sharon\u00a0E. Davis, Robert\u00a0A. Greevy, Christopher\u00a0J Fonnesbeck, Thomas\u00a0A. Lasko, Colin\u00a0G. Walsh, and Michael\u00a0E. Matheny. 2019. A nonparametric updating method to correct clinical prediction model drift. Journal of the American Medical Informatics Association : JAMIA (2019)."},{"key":"e_1_3_2_1_63_1","volume-title":"\u00a0M. Moons","author":"Debray Thomas","year":"2015","unstructured":"Thomas P.\u00a0A. Debray, Yvonne Vergouwe, Hendrik Koffijberg, Daan Nieboer, Ewout\u00a0Willem Steyerberg, and Karel G.\u00a0M. Moons. 2015. A new framework to enhance the interpretation of external validation studies of clinical prediction models.Journal of clinical epidemiology 68 3 (2015), 279\u201389."},{"key":"e_1_3_2_1_64_1","unstructured":"Nina Deliu Joseph\u00a0J Williams and Sofia\u00a0S Villar. 2021. Efficient Inference Without Trading-off Regret in Bandits: An Allocation Probability Test for Thompson Sampling. arXiv preprint arXiv:2111.00137(2021)."},{"key":"e_1_3_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2006.017681"},{"key":"e_1_3_2_1_66_1","volume-title":"CA: A Cancer Journal for Clinicians 66","author":"DeSantis C.","year":"2016","unstructured":"C. DeSantis, R. Siegel, A. Sauer, K. Miller, S. Fedewa, Kassandra\u00a0I. Alcaraz, and A. Jemal. 2016. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA: A Cancer Journal for Clinicians 66 (2016)."},{"key":"e_1_3_2_1_67_1","first-page":"152","article-title":"Generalization of Machine Learning Approaches to Identify Notifiable Conditions from a Statewide Health Information Exchange.AMIA Joint Summits on Translational Science proceedings","volume":"2020","author":"Dexter P.","year":"2020","unstructured":"Gregory\u00a0P. Dexter, Shaun\u00a0J. Grannis, Brian\u00a0E. Dixon, and Suranga\u00a0Nath Kasthurirathne. 2020. Generalization of Machine Learning Approaches to Identify Notifiable Conditions from a Statewide Health Information Exchange.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science 2020 (2020), 152\u2013161.","journal-title":"AMIA Joint Summits on Translational Science"},{"key":"e_1_3_2_1_68_1","volume-title":"Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.Archives of internal medicine 168 2","author":"Dhruva S.","year":"2008","unstructured":"Sanket\u00a0S. Dhruva and Rita\u00a0F. Redberg. 2008. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.Archives of internal medicine 168 2 (2008), 136\u201340."},{"key":"e_1_3_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2005.013763"},{"key":"e_1_3_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.9.905"},{"key":"e_1_3_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/frobt.2017.00071"},{"key":"e_1_3_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.2307\/3562720"},{"key":"e_1_3_2_1_73_1","volume-title":"Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.Journal of oncology practice 14 1","author":"Duma Narjust","year":"2018","unstructured":"Narjust Duma, Jesus\u00a0Vera Aguilera, Jonas Paludo, Candace\u00a0L Haddox, Miguel\u00a0Gonzalez Velez, Yucai Wang, Konstantinos Leventakos, Joleen\u00a0M Hubbard, Aaron\u00a0S. Mansfield, Ronald\u00a0S. Go, and Alex\u00a0A. Adjei. 2018. Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.Journal of oncology practice 14 1 (2018), e1\u2013e10."},{"key":"e_1_3_2_1_74_1","doi-asserted-by":"crossref","unstructured":"C. Dwork Moritz Hardt T. Pitassi O. Reingold and R. Zemel. 2012. Fairness through awareness. ArXiv abs\/1104.3913(2012).","DOI":"10.1145\/2090236.2090255"},{"key":"e_1_3_2_1_75_1","volume-title":"Edwards and Glyn Elwyn","author":"Adrian","year":"2001","unstructured":"Adrian G.\u00a0K. Edwards and Glyn Elwyn. 2001. Understanding risk and lessons for clinical risk communication about treatment preferences. BMJ Quality & Safety 10(2001)."},{"key":"e_1_3_2_1_76_1","doi-asserted-by":"crossref","unstructured":"Ezekiel\u00a0J. Emanuel David Wendler and Christine Grady. 2000. What makes clinical research ethical?JAMA 283 20(2000) 2701\u201311.","DOI":"10.1001\/jama.283.20.2701"},{"key":"e_1_3_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1177\/0306312708091930"},{"key":"e_1_3_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1070984"},{"key":"e_1_3_2_1_79_1","volume-title":"Maternal vaccination: moving the science forward.Human reproduction update 21 1","author":"Faucette N.","year":"2015","unstructured":"Azure\u00a0N. Faucette, Benjamin\u00a0L. Unger, Bernard Gonik, and Kang Chen. 2015. Maternal vaccination: moving the science forward.Human reproduction update 21 1 (2015), 119\u201335."},{"key":"e_1_3_2_1_80_1","volume-title":"Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining(2015)","author":"Feldman Michael","unstructured":"Michael Feldman, Sorelle\u00a0A. Friedler, John Moeller, C. Scheidegger, and S. Venkatasubramanian. 2015. Certifying and Removing Disparate Impact. Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining(2015)."},{"key":"e_1_3_2_1_81_1","first-page":"543","article-title":"Artificial intelligence can entrench disparities\u2014here\u2019s what we must do","volume":"44","author":"Ferryman Kadija","year":"2018","unstructured":"Kadija Ferryman. 2018. Artificial intelligence can entrench disparities\u2014here\u2019s what we must do. The Cancer Letter 44(2018), 543.","journal-title":"The Cancer Letter"},{"key":"e_1_3_2_1_82_1","volume-title":"Challenging assumptions about minority participation in US clinical research.American journal of public health 101 12","author":"Fisher A.","year":"2011","unstructured":"Jill\u00a0A. Fisher and Corey\u00a0A. Kalbaugh. 2011. Challenging assumptions about minority participation in US clinical research.American journal of public health 101 12 (2011), 2217\u201322."},{"key":"e_1_3_2_1_83_1","unstructured":"Center for Drug\u00a0Evaluation and Research. [n. d.]. (irbs) and protection of human subjects. https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/institutional-review-boards-irbs-and-protection-human-subjects-clinical-trials"},{"key":"e_1_3_2_1_85_1","volume-title":"Equipoise and the ethics of clinical research.The New England journal of medicine 317 3","author":"Freedman Benjamin","year":"1987","unstructured":"Benjamin Freedman. 1987. Equipoise and the ethics of clinical research.The New England journal of medicine 317 3 (1987), 141\u20135."},{"key":"e_1_3_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201900020"},{"key":"e_1_3_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1145\/3433949"},{"key":"e_1_3_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1145\/230538.230561"},{"key":"e_1_3_2_1_89_1","volume-title":"Generalization in Clinical Prediction Models: The Blessing and Curse of Measurement Indicator Variables. Critical Care Explorations 3","author":"Futoma D.","year":"2021","unstructured":"Joseph\u00a0D. Futoma, Morgan\u00a0G. Simons, Finale Doshi-Velez, and Rishikesan Kamaleswaran. 2021. Generalization in Clinical Prediction Models: The Blessing and Curse of Measurement Indicator Variables. Critical Care Explorations 3 (2021)."},{"key":"e_1_3_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30186-2"},{"key":"e_1_3_2_1_91_1","doi-asserted-by":"crossref","unstructured":"Nicole\u00a0B Gabler Naihua Duan Eli Raneses Leah\u00a0H Suttner Michael Ciarametaro Elizabeth Cooney Robert\u00a0W. Dubois Scott\u00a0D. Halpern and Richard\u00a0L. Kravitz. 2016. No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals. Trials 17(2016).","DOI":"10.1186\/s13063-016-1447-5"},{"key":"e_1_3_2_1_92_1","volume-title":"Equity in essence: a call for operationalising fairness in machine learning for healthcare.BMJ health & care informatics 28 1","author":"Gichoya Judy\u00a0Wawira","year":"2021","unstructured":"Judy\u00a0Wawira Gichoya, Liam\u00a0G. McCoy, Leo\u00a0Anthony Celi, and Marzyeh Ghassemi. 2021. Equity in essence: a call for operationalising fairness in machine learning for healthcare.BMJ health & care informatics 28 1 (2021)."},{"key":"e_1_3_2_1_93_1","unstructured":"Stephen Gillen Christopher Jung Michael Kearns and Aaron Roth. 2018. Online Learning with an Unknown Fairness Metric. ArXiv abs\/1802.06936(2018)."},{"key":"e_1_3_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1142\/9789813235533_0014"},{"key":"e_1_3_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.24251\/HICSS.2019.258"},{"key":"e_1_3_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1109\/ITA50056.2020.9244948"},{"key":"e_1_3_2_1_97_1","unstructured":"Shengbo Guo and Scott Sanner. 2010. Real-time Multiattribute Bayesian Preference Elicitation with Pairwise Comparison Queries. In AISTATS."},{"key":"e_1_3_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-009-9539-9"},{"key":"e_1_3_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014602118"},{"key":"e_1_3_2_1_100_1","volume-title":"Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice.Journal of Clinical Oncology 36","author":"Haddad C.","year":"2018","unstructured":"Tufia\u00a0C. Haddad, Jane\u00a0M Helgeson, Katharine\u00a0E Pomerleau, Marissa Makey, Phillip Lombardo, Sadie Coverdill, Alexandra Urman, Melissa Rammage, Matthew\u00a0P. Goetz, and Nicholas\u00a0F. LaRusso. 2018. Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice.Journal of Clinical Oncology 36 (2018), 6550\u20136550."},{"key":"e_1_3_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.5555\/945365.945385"},{"key":"e_1_3_2_1_102_1","volume-title":"Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.Cancer control : journal of the Moffitt Cancer Center 23 4","author":"Hamel M.","year":"2016","unstructured":"Lauren\u00a0M. Hamel, Louis\u00a0A Penner, Terrance\u00a0L Albrecht, Elisabeth\u00a0I. Heath, Clement\u00a0K. Gwede, and Susan Eggly. 2016. Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.Cancer control : journal of the Moffitt Cancer Center 23 4 (2016), 327\u2013337."},{"key":"e_1_3_2_1_103_1","unstructured":"Moritz Hardt Eric Price and Nathan Srebro. 2016. Equality of Opportunity in Supervised Learning. In NIPS."},{"key":"e_1_3_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.12.1233"},{"key":"e_1_3_2_1_105_1","doi-asserted-by":"crossref","unstructured":"Hamed Hassanzadeh Sarvnaz Karimi and Anthony\u00a0N. Nguyen. 2020. Matching patients to clinical trials using semantically enriched document representation. Journal of biomedical informatics(2020) 103406.","DOI":"10.1016\/j.jbi.2020.103406"},{"key":"e_1_3_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0028-y"},{"key":"e_1_3_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e318181e4c7"},{"key":"e_1_3_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-6-18"},{"key":"e_1_3_2_1_109_1","volume-title":"Representation of the elderly, women, and minorities in heart failure clinical trials.Archives of internal medicine 162 15","author":"Heiat Asefeh","year":"2002","unstructured":"Asefeh Heiat, Cary\u00a0P. Gross, and Harlan\u00a0M. Krumholz. 2002. Representation of the elderly, women, and minorities in heart failure clinical trials.Archives of internal medicine 162 15 (2002), 1682\u20138."},{"key":"e_1_3_2_1_110_1","volume-title":"Charles\u00a0W. Lidz, Franklin\u00a0G. Miller","author":"Henderson E.","unstructured":"Gail\u00a0E. Henderson, Larry\u00a0R. Churchill, Arlene\u00a0M. Davis, Michele\u00a0M Easter, Christine Grady, Steven Joffe, Nancy\u00a0E. Kass, Nancy M\u00a0P King, Charles\u00a0W. Lidz, Franklin\u00a0G. Miller, Daniel\u00a0K. Nelson, Jeffrey Peppercorn, Barbra\u00a0Bluestone Rothschild, Pamela\u00a0L Sankar, Benjamin\u00a0S. Wilfond, and Catherine\u00a0R. Zimmer. 2007. Clinical Trials and Medical Care: Defining the Therapeutic Misconception. PLoS Medicine 4(2007)."},{"key":"e_1_3_2_1_111_1","doi-asserted-by":"crossref","unstructured":"E. Hing and E. Burt. 2009. Are There Patient Disparities When Electronic Health Records Are Adopted?Journal of Health Care for the Poor and Underserved 20 (2009) 473 \u2013 488.","DOI":"10.1353\/hpu.0.0143"},{"key":"e_1_3_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1145\/3290605.3300830"},{"key":"e_1_3_2_1_113_1","doi-asserted-by":"crossref","unstructured":"Felix Holzmeister and Matthias Stefan. 2019. The Risk Elicitation Puzzle Revisited: Across-Methods (In)consistency?","DOI":"10.31219\/osf.io\/pj9u2"},{"key":"e_1_3_2_1_114_1","volume-title":"Reasons for Exclusion from a Smoking Cessation Trial: An Analysis by Race\/Ethnicity.Ethnicity & disease 29 1","author":"Hooper Monica\u00a0Webb","year":"2019","unstructured":"Monica\u00a0Webb Hooper, Taghrid Asfar, Marina Unrod, Asha Dorsey, John\u00a0B. Correa, Karen\u00a0O Brandon, Vani\u00a0N. Simmons, Michael\u00a0A Antoni, Tulay Koru-Sengul, David\u00a0J Lee, and Thomas\u00a0H Brandon. 2019. Reasons for Exclusion from a Smoking Cessation Trial: An Analysis by Race\/Ethnicity.Ethnicity & disease 29 1 (2019), 23\u201330."},{"key":"e_1_3_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1145\/3366423.3380228"},{"key":"e_1_3_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1214\/20-AOS1991"},{"key":"e_1_3_2_1_117_1","unstructured":"Lily Hu and Issa Kohler-Hausmann. 2020. What\u2019s sex got to do with fair machine learning?arXiv preprint arXiv:2006.01770(2020)."},{"key":"e_1_3_2_1_118_1","unstructured":"Christina Ilvento. 2019. Metric learning for individual fairness. arXiv preprint arXiv:1906.00250(2019)."},{"key":"e_1_3_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202101-0117OC"},{"key":"e_1_3_2_1_120_1","volume-title":"The impact of high-risk patients on the results of clinical trials.Journal of clinical epidemiology 50 10","author":"Ioannidis Jpa","year":"1997","unstructured":"Jpa Ioannidis and Joseph Lau. 1997. The impact of high-risk patients on the results of clinical trials.Journal of clinical epidemiology 50 10 (1997), 1089\u201398."},{"key":"e_1_3_2_1_121_1","volume-title":"Ioannidis and Joseph Lau","author":"John","year":"1998","unstructured":"John P.\u00a0A. Ioannidis and Joseph Lau. 1998. Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm.American journal of epidemiology 148 11 (1998), 1117\u201326."},{"key":"e_1_3_2_1_122_1","unstructured":"S. Jabbari Matthew Joseph M. Kearns Jamie\u00a0H. Morgenstern and Aaron Roth. 2017. Fairness in Reinforcement Learning. In ICML."},{"key":"e_1_3_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106590"},{"key":"e_1_3_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0084-2"},{"key":"e_1_3_2_1_125_1","unstructured":"Matthew Joseph M. Kearns Jamie\u00a0H. Morgenstern and Aaron Roth. 2016. Fairness in Learning: Classic and Contextual Bandits. ArXiv abs\/1605.07139(2016)."},{"key":"e_1_3_2_1_126_1","unstructured":"Christopher Jung Sampath Kannan and Neil Lutz. 2020. Quantifying the Burden of Exploration and the Unfairness of Free Riding. ArXiv abs\/1810.08743(2020)."},{"key":"e_1_3_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780040204"},{"key":"e_1_3_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1214\/19-AOS1938"},{"key":"e_1_3_2_1_129_1","doi-asserted-by":"crossref","unstructured":"Christopher\u00a0J. Kelly Alan Karthikesalingam Mustafa Suleyman Greg Corrado and Dominic King. 2019. Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine 17(2019).","DOI":"10.1186\/s12916-019-1426-2"},{"key":"e_1_3_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.20.2.164"},{"key":"e_1_3_2_1_131_1","doi-asserted-by":"crossref","unstructured":"Tessa Kennedy-Martin Sarah\u00a0E. Curtis Douglas\u00a0E Faries Susan Robinson and Joseph\u00a0A Johnston. 2015. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16(2015).","DOI":"10.1186\/s13063-015-1023-4"},{"key":"e_1_3_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-9-30"},{"key":"e_1_3_2_1_133_1","doi-asserted-by":"crossref","unstructured":"David\u00a0M. Kent and Rodney\u00a0A. Hayward. 2007. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.JAMA 298 10(2007) 1209\u201312.","DOI":"10.1001\/jama.298.10.1209"},{"key":"e_1_3_2_1_134_1","volume-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. British Medical Journal 363","author":"Kent M.","year":"2018","unstructured":"David\u00a0M. Kent, Ewout\u00a0Willem Steyerberg, and David van Klaveren. 2018. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. British Medical Journal 363 (2018)."},{"key":"e_1_3_2_1_135_1","volume-title":"Stratified randomization for clinical trials.Journal of clinical epidemiology 52 1","author":"Kernan N.","year":"1999","unstructured":"Walter\u00a0N. Kernan, Catherine\u00a0M. Viscoli, Robert\u00a0W. Makuch, Lawrence\u00a0M. Brass, and Ralph\u00a0I Horwitz. 1999. Stratified randomization for clinical trials.Journal of clinical epidemiology 52 1 (1999), 19\u201326."},{"key":"e_1_3_2_1_136_1","volume-title":"International Conference on Artificial Intelligence and Statistics. PMLR, 277\u2013287","author":"Kilbertus Niki","year":"2020","unstructured":"Niki Kilbertus, Manuel\u00a0Gomez Rodriguez, Bernhard Sch\u00f6lkopf, Krikamol Muandet, and Isabel Valera. 2020. Fair decisions despite imperfect predictions. In International Conference on Artificial Intelligence and Statistics. PMLR, 277\u2013287."},{"key":"e_1_3_2_1_137_1","volume-title":"Advances in Neural Information Processing Systems, I.\u00a0Guyon, U.\u00a0V. Luxburg, S.\u00a0Bengio, H.\u00a0Wallach, R.\u00a0Fergus, S.\u00a0Vishwanathan, and R.\u00a0Garnett (Eds.). Vol.\u00a030. Curran Associates","author":"Kilbertus Niki","year":"2017","unstructured":"Niki Kilbertus, Mateo Rojas\u00a0Carulla, Giambattista Parascandolo, Moritz Hardt, Dominik Janzing, and Bernhard Sch\u00f6lkopf. 2017. Avoiding Discrimination through Causal Reasoning. In Advances in Neural Information Processing Systems, I.\u00a0Guyon, U.\u00a0V. Luxburg, S.\u00a0Bengio, H.\u00a0Wallach, R.\u00a0Fergus, S.\u00a0Vishwanathan, and R.\u00a0Garnett (Eds.). Vol.\u00a030. Curran Associates, Inc.https:\/\/proceedings.neurips.cc\/paper\/2017\/file\/f5f8590cd58a54e94377e6ae2eded4d9-Paper.pdf"},{"key":"e_1_3_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa276"},{"key":"e_1_3_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1145\/3306618.3314287"},{"key":"e_1_3_2_1_140_1","unstructured":"Michael\u00a0P. Kim Aleksandra Korolova Guy\u00a0N. Rothblum and G. Yona. 2020. Preference-Informed Fairness. In ITCS."},{"key":"e_1_3_2_1_141_1","doi-asserted-by":"crossref","unstructured":"Michael King Irwin Nazareth Fiona Lampe Peter Bower Martin Chandler M Morou Bonnie Sibbald and Rosalind Lai. 2005. Impact of participant and physician intervention preferences on randomized trials: a systematic review.JAMA 293 9(2005) 1089\u201399.","DOI":"10.1001\/jama.293.9.1089"},{"key":"e_1_3_2_1_142_1","unstructured":"J. Kleinberg S. Mullainathan and M. Raghavan. 2017. Inherent Trade-Offs in the Fair Determination of Risk Scores. ArXiv abs\/1609.05807(2017)."},{"key":"e_1_3_2_1_143_1","volume-title":"Teaching the responsible conduct of research in humans (RCRH)","author":"Korenman G","year":"2006","unstructured":"Stanley\u00a0G Korenman. 2006. Teaching the responsible conduct of research in humans (RCRH). Los Angeles: University of California(2006)."},{"key":"e_1_3_2_1_144_1","unstructured":"Matt\u00a0J. Kusner Joshua\u00a0R. Loftus Chris Russell and Ricardo Silva. 2017. Counterfactual Fairness. In NIPS."},{"key":"e_1_3_2_1_145_1","volume-title":"Ethical considerations in adaptive design clinical trials. Therapeutic innovation & regulatory science 51, 2","author":"Laage Thomas","year":"2017","unstructured":"Thomas Laage, John\u00a0W Loewy, Sandeep Menon, Eva\u00a0R Miller, Erik Pulkstenis, Natalia Kan-Dobrosky, and Christopher Coffey. 2017. Ethical considerations in adaptive design clinical trials. Therapeutic innovation & regulatory science 51, 2 (2017), 190\u2013199."},{"key":"e_1_3_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-8858(85)90002-8"},{"key":"e_1_3_2_1_147_1","volume-title":"Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared. BMC Medical Research Methodology 15","author":"Lambooij S.","year":"2015","unstructured":"Mattijs\u00a0S. Lambooij, Irene\u00a0Anhai Harmsen, Jorien Veldwijk, Hester\u00a0E. de Melker, Liesbeth Mollema, Yolanda\u00a0WM van Weert, and G.\u00a0Ardine de Wit. 2015. Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared. BMC Medical Research Methodology 15 (2015)."},{"key":"e_1_3_2_1_148_1","volume-title":"International Conference on Artificial Intelligence and Statistics. PMLR, 2645\u20132654","author":"Lee Hyun-Suk","year":"2020","unstructured":"Hyun-Suk Lee, Cong Shen, James Jordon, and Mihaela Schaar. 2020. Contextual constrained learning for dose-finding clinical trials. In International Conference on Artificial Intelligence and Statistics. PMLR, 2645\u20132654."},{"key":"e_1_3_2_1_149_1","unstructured":"Hyun-Suk Lee Cong Shen James Jordon and Mihaela van\u00a0der Schaar. 2020. Contextual Constrained Learning for Dose-Finding Clinical Trials. In AISTATS."},{"key":"e_1_3_2_1_150_1","unstructured":"Hyun-Suk Lee Cong Shen William\u00a0R. Zame Jang-Won Lee and Mihaela van\u00a0der Schaar. 2021. SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups. In AISTATS."},{"key":"e_1_3_2_1_151_1","doi-asserted-by":"crossref","unstructured":"Jinhee Lee Hanwul Shin Jun\u00a0Young Lee Jae\u00a0Seok Kim Jae-Won Yang Keumwha Lee Andreas Kronbichler and Jae\u00a0Il Shin. 2020. A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era. Medicina 56(2020).","DOI":"10.3390\/medicina56060315"},{"key":"e_1_3_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774514568875"},{"key":"e_1_3_2_1_153_1","doi-asserted-by":"crossref","unstructured":"Laurie\u00a0J. Legocki William\u00a0J. Meurer Shirley\u00a0M. Frederiksen Roger\u00a0J. Lewis Valerie\u00a0L. Durkalski Donald\u00a0A. Berry William\u00a0G. Barsan and Michael\u00a0Derwin Fetters. 2015. Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis. BMC Medical Ethics 16(2015).","DOI":"10.1186\/s12910-015-0022-z"},{"key":"e_1_3_2_1_154_1","volume-title":"International ethical guidelines for biomedical research involving human subjects.Bulletin of medical ethics 182","author":"Levine J.","year":"2002","unstructured":"Robert\u00a0J. Levine. 2002. International ethical guidelines for biomedical research involving human subjects.Bulletin of medical ethics 182 (2002), 17\u201323."},{"key":"e_1_3_2_1_155_1","volume-title":"Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Science Translational Medicine 7","author":"Li Lei","year":"2015","unstructured":"Lei Li, Wei-Yi Cheng, Benjamin\u00a0S. Glicksberg, Omri Gottesman, Ronald Tamler, Rong Chen, Erwin\u00a0P. Bottinger, and Joel\u00a0T. Dudley. 2015. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Science Translational Medicine 7 (2015), 311ra174 \u2013 311ra174."},{"key":"e_1_3_2_1_156_1","volume-title":"Annual Symposium proceedings. AMIA Symposium 2019","author":"Li Qian","year":"2019","unstructured":"Qian Li, Zhe He, Yi Guo, Hansi Zhang, Thomas\u00a0J. George, William\u00a0R. Hogan, Neil Charness, and J. Bian. 2019. Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study. AMIA... Annual Symposium proceedings. AMIA Symposium 2019 (2019), 1101\u20131110."},{"key":"e_1_3_2_1_157_1","doi-asserted-by":"crossref","unstructured":"Katherine\u00a0P. Liao Tianxi Cai Guergana\u00a0K. Savova Shawn\u00a0N. Murphy Elizabeth\u00a0W. Karlson Ashwin\u00a0N. Ananthakrishnan Vivian\u00a0S. Gainer Stanley\u00a0Y. Shaw Zongqi Xia Peter Szolovits Susanne\u00a0E. Churchill and Isaac\u00a0S. Kohane. 2015. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. The BMJ 350(2015).","DOI":"10.1136\/bmj.h1885"},{"key":"e_1_3_2_1_158_1","volume-title":"Equipoise and the ethics of randomization.Journal of the Royal Society of Medicine 88, 10","author":"Lilford J","year":"1995","unstructured":"Richard\u00a0J Lilford and Jennifer Jackson. 1995. Equipoise and the ethics of randomization.Journal of the Royal Society of Medicine 88, 10 (1995), 552."},{"key":"e_1_3_2_1_159_1","unstructured":"Abby Lippman. 2006. The Inclusion of Women in Clinical Trials: Are We Asking the Right Questions?"},{"key":"e_1_3_2_1_160_1","volume-title":"Evaluating eligibility criteria of oncology trials using real-world data and AI.Nature","author":"Liu Ruishan","year":"2021","unstructured":"Ruishan Liu, Shemra Rizzo, Sam Whipple, Navdeep Pal, Arturo\u00a0L\u00f3pez Pineda, Michael Lu, Brandon Arnieri, Ying Lu, William\u00a0B. Capra, Ryan Copping, and James Zou. 2021. Evaluating eligibility criteria of oncology trials using real-world data and AI.Nature (2021)."},{"key":"e_1_3_2_1_161_1","unstructured":"Xiaoxuan Liu Samantha\u00a0Cruz Rivera David Moher Melanie\u00a0Jane Calvert Alastair\u00a0K. Denniston Hutan Ashrafian Andrew Beam An-Wen Chan Gary\u00a0S. Collins Ara Darzi Jonathan\u00a0J. Deeks Mohammed\u00a0K. Elzarrad Cyrus Espinoza Andre Esteva Livia Faes Lavinia\u00a0Ferrante di Ruffano J Fletcher Robert\u00a0M. Golub Hugh Harvey Charlotte\u00a0J Haug Christopher Holmes Adrian Jonas Pearse\u00a0A. Keane Christopher\u00a0J. Kelly Aaron\u00a0Y. Lee Cecilia\u00a0S. Lee Elaine Manna James Matcham Melissa\u00a0D. McCradden Joao Monteiro Cynthia\u00a0D. Mulrow Luke Oakden-Rayner Dina\u00a0N. Paltoo Maria\u00a0Beatrice Panico Gary Price Samuel d. Rowley Richard Savage Rupa Sarkar Sebastian\u00a0J. Vollmer and Christopher Yau. 2020. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension. The BMJ 370(2020)."},{"key":"e_1_3_2_1_162_1","unstructured":"Y. Liu Goran Radanovic Christos Dimitrakakis Debmalya Mandal and D. Parkes. 2017. Calibrated Fairness in Bandits. ArXiv abs\/1707.01875(2017)."},{"key":"e_1_3_2_1_163_1","volume-title":"Patients","author":"Llewellyn-Thomas Hilary","year":"1991","unstructured":"Hilary Llewellyn-Thomas, M\u00a0J McGreal, Elaine\u00a0C. Thiel, Sheldon Fine, and Charles Erlichman. 1991. Patients\u2019 willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.Social science & medicine 32 1 (1991), 35\u201342."},{"key":"e_1_3_2_1_164_1","unstructured":"Joshua\u00a0R. Loftus Chris Russell Matt\u00a0J. Kusner and Ricardo Silva. 2018. Causal Reasoning for Algorithmic Fairness. ArXiv abs\/1805.05859(2018)."},{"key":"e_1_3_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2017-104549"},{"key":"e_1_3_2_1_166_1","unstructured":"David Madras Elliot Creager T. Pitassi and R. Zemel. 2018. Learning Adversarially Fair and Transferable Representations. In ICML."},{"key":"e_1_3_2_1_167_1","volume-title":"Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.American heart journal 146 2","author":"Masoudi A.","year":"2003","unstructured":"Frederick\u00a0A. Masoudi, Edward\u00a0P. Havranek, Pam Wolfe, Cary\u00a0P. Gross, Saif\u00a0S. Rathore, John\u00a0F. Steiner, Diana\u00a0L. Ordin, and Harlan\u00a0M. Krumholz. 2003. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.American heart journal 146 2 (2003), 250\u20137."},{"key":"e_1_3_2_1_168_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001888-199409000-00002"},{"key":"e_1_3_2_1_169_1","doi-asserted-by":"crossref","unstructured":"Gillian McKay and Shelley Lees. 2020. Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic.Obstetrics & Gynecology(2020).","DOI":"10.1097\/AOG.0000000000004036"},{"key":"e_1_3_2_1_170_1","doi-asserted-by":"crossref","unstructured":"Richard\u00a0P. McQuellon Hyman\u00a0B. Muss S. Hoffman Greg Russell B.\u00a0Cathy Craven and Suzanne\u00a0B. Yellen. 1995. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 13 4 (1995) 858\u201368.","DOI":"10.1200\/JCO.1995.13.4.858"},{"key":"e_1_3_2_1_171_1","doi-asserted-by":"publisher","DOI":"10.1145\/3457607"},{"key":"e_1_3_2_1_172_1","doi-asserted-by":"crossref","unstructured":"William\u00a0J. Meurer Roger\u00a0J. Lewis and Donald\u00a0A. Berry. 2012. Adaptive clinical trials: a partial remedy for the therapeutic misconception?JAMA 307 22(2012) 2377\u20138.","DOI":"10.1001\/jama.2012.4174"},{"key":"e_1_3_2_1_173_1","volume-title":"Miller and Howard Brody","author":"G.","year":"2003","unstructured":"Franklin\u00a0G. Miller and Howard Brody. 2003. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.The Hastings Center report 33 3 (2003), 19\u201328."},{"key":"e_1_3_2_1_174_1","volume-title":"Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance.Gynecologic oncology 140 2","author":"Minion E.","year":"2016","unstructured":"Lindsey\u00a0E. Minion, Robert\u00a0L. Coleman, Ronald\u00a0D. Alvarez, and Thomas\u00a0J. Herzog. 2016. Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance.Gynecologic oncology 140 2 (2016), 193\u20138."},{"key":"e_1_3_2_1_175_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocu050"},{"key":"e_1_3_2_1_176_1","doi-asserted-by":"crossref","unstructured":"Jessica Mozersky Douglas\u00a0L Mann and James\u00a0M DuBois. 2020. The National Institute of Allergy and Infectious Diseases decision to stop the adaptive COVID-19 trial: on solid ethical and scientific grounds. 645\u2013647\u00a0pages.","DOI":"10.1016\/j.jacbts.2020.05.002"},{"key":"e_1_3_2_1_177_1","volume-title":"International Conference on Machine Learning. PMLR, 7097\u20137107","author":"Mukherjee Debarghya","year":"2020","unstructured":"Debarghya Mukherjee, Mikhail Yurochkin, Moulinath Banerjee, and Yuekai Sun. 2020. Two simple ways to learn individual fairness metrics from data. In International Conference on Machine Learning. PMLR, 7097\u20137107."},{"key":"e_1_3_2_1_178_1","volume-title":"Enhancing Multi-Center Generalization of Machine Learning-Based Depression Diagnosis From Resting-State fMRI. Frontiers in Psychiatry 11","author":"Nakano Takashi","year":"2020","unstructured":"Takashi Nakano, Masahiro Takamura, Naho Ichikawa, Go Okada, Yasumasa Okamoto, Makiko Yamada, Tetsuya Suhara, Shigeto Yamawaki, and Junichiro Yoshimoto. 2020. Enhancing Multi-Center Generalization of Machine Learning-Based Depression Diagnosis From Resting-State fMRI. Frontiers in Psychiatry 11 (2020)."},{"key":"e_1_3_2_1_179_1","unstructured":"Cecilia Nardini. 2014. The ethics of clinical trials. ecancermedicalscience 8(2014)."},{"key":"e_1_3_2_1_180_1","volume-title":"Unequal treatment: confronting racial and ethnic disparities in health care.Journal of the National Medical Association 94 8","author":"Nelson R.","year":"2002","unstructured":"Alan\u00a0R. Nelson. 2002. Unequal treatment: confronting racial and ethnic disparities in health care.Journal of the National Medical Association 94 8 (2002), 666\u20138."},{"key":"e_1_3_2_1_181_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocv216"},{"key":"e_1_3_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2014-002887"},{"key":"e_1_3_2_1_183_1","volume-title":"American Society of Clinical Oncology. Annual Meeting 39","author":"Nipp D.","year":"2019","unstructured":"Ryan\u00a0D. Nipp, Kessely Hong, and Electra\u00a0D. Paskett. 2019. Overcoming Barriers to Clinical Trial Enrollment.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 39 (2019), 105\u2013114."},{"key":"e_1_3_2_1_184_1","volume-title":"Predicting the future\u2014big data, machine learning, and clinical medicine. The New England journal of medicine 375, 13","author":"Obermeyer Ziad","year":"2016","unstructured":"Ziad Obermeyer and Ezekiel\u00a0J Emanuel. 2016. Predicting the future\u2014big data, machine learning, and clinical medicine. The New England journal of medicine 375, 13 (2016), 1216."},{"key":"e_1_3_2_1_185_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax2342"},{"key":"e_1_3_2_1_186_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2015.1092034"},{"key":"e_1_3_2_1_187_1","volume-title":"Adaptive designs in clinical trials: why use them, and how to run and report them. BMC medicine 16, 1","author":"Pallmann Philip","year":"2018","unstructured":"Philip Pallmann, Alun\u00a0W Bedding, Babak Choodari-Oskooei, Munyaradzi Dimairo, Laura Flight, Lisa\u00a0V Hampson, Jane Holmes, Adrian\u00a0P Mander, Lang\u2019o Odondi, Matthew\u00a0R Sydes, 2018. Adaptive designs in clinical trials: why use them, and how to run and report them. BMC medicine 16, 1 (2018), 1\u201315."},{"key":"e_1_3_2_1_188_1","volume-title":"David Ruben\u00a0Teindl Laursen, and Asbj\u00f8rn Hr\u00f3bjartsson","author":"Paludan-M\u00fcller Asger","year":"2016","unstructured":"Asger Paludan-M\u00fcller, David Ruben\u00a0Teindl Laursen, and Asbj\u00f8rn Hr\u00f3bjartsson. 2016. Mechanisms and direction of allocation bias in randomised clinical trials. BMC medical research methodology 16, 1 (2016), 1\u201310."},{"key":"e_1_3_2_1_189_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S156708"},{"key":"e_1_3_2_1_190_1","unstructured":"Vishakha Patil Ganesh Ghalme Vineet\u00a0J. Nair and Y. Narahari. 2020. Achieving Fairness in the Stochastic Multi-armed Bandit Problem. ArXiv abs\/1907.10516(2020)."},{"key":"e_1_3_2_1_191_1","doi-asserted-by":"crossref","unstructured":"J. Paulus and D. Kent. 2020. Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase health disparities. NPJ Digital Medicine 3(2020).","DOI":"10.1038\/s41746-020-0304-9"},{"key":"e_1_3_2_1_192_1","unstructured":"J. Pearl. 2000. Causality: Models Reasoning and Inference. In None."},{"key":"e_1_3_2_1_193_1","volume-title":"The use of unequal randomisation in clinical trials\u2014an update. Contemporary clinical trials 45","author":"Peckham Emily","year":"2015","unstructured":"Emily Peckham, Sally Brabyn, Liz Cook, Thomas Devlin, Jo Dumville, and David\u00a0J Torgerson. 2015. The use of unequal randomisation in clinical trials\u2014an update. Contemporary clinical trials 45 (2015), 113\u2013122."},{"key":"e_1_3_2_1_194_1","doi-asserted-by":"crossref","unstructured":"S. Pfohl Agata Foryciarz and N. Shah. 2021. An Empirical Characterization of Fair Machine Learning For Clinical Risk Prediction. Journal of biomedical informatics(2021) 103621.","DOI":"10.1016\/j.jbi.2020.103621"},{"key":"e_1_3_2_1_195_1","volume-title":"Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.Statistics in medicine 21 19","author":"Pocock J","year":"2002","unstructured":"Stuart\u00a0J Pocock, Susan\u00a0E Assmann, Laura\u00a0E Enos, and Linda\u00a0E Kasten. 2002. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.Statistics in medicine 21 19 (2002), 2917\u201330."},{"key":"e_1_3_2_1_196_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11257-011-9116-6"},{"key":"e_1_3_2_1_197_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912378106"},{"key":"e_1_3_2_1_198_1","unstructured":"Miao Qi Owen Cahan Morgan Foreman Daniel Gruen A.\u00a0K. Das and Kathleen\u00a0P. Bennett. 2021. Quantifying representativeness in randomized clinical trials using machine learning fairness metrics. In medRxiv."},{"key":"e_1_3_2_1_199_1","unstructured":"M. Raghavan Aleksandrs Slivkins Jennifer\u00a0Wortman Vaughan and Z. Wu. 2018. The Externalities of Exploration and How Data Diversity Helps Exploitation. ArXiv abs\/1806.00543(2018)."},{"key":"e_1_3_2_1_200_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1814259"},{"key":"e_1_3_2_1_201_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1990"},{"key":"e_1_3_2_1_202_1","doi-asserted-by":"crossref","unstructured":"Meghna Ranganathan and Raj\u00a0S Bhopal. 2006. Exclusion and Inclusion of Nonwhite Ethnic Minority Groups in 72 North American and European Cardiovascular Cohort Studies. PLoS Medicine 3(2006).","DOI":"10.1371\/journal.pmed.0030044"},{"key":"e_1_3_2_1_203_1","doi-asserted-by":"crossref","unstructured":"John Rawls. 1971. A Theory of Justice: Revised Edition.","DOI":"10.4159\/9780674042605"},{"key":"e_1_3_2_1_204_1","doi-asserted-by":"crossref","unstructured":"Shelby\u00a0D Reed Jui-Chen Yang Timothy Rickert F.\u00a0Reed Johnson Juan\u00a0Marcos Gonzalez Robert\u00a0J. Mentz Mitchell\u00a0W. Krucoff Sreekanth Vemulapalli Philip\u00a0B. Adamson David\u00a0J. Gebben Liliana Rincon-Gonzalez Anindita Saha Daniel\u00a0E Schaber Kenneth\u00a0M. Stein Michelle\u00a0E Tarver and Dean Bruhn-Ding. 2021. Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.Circulation. Heart failure(2021) CIRCHEARTFAILURE121008797.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008797"},{"key":"e_1_3_2_1_205_1","doi-asserted-by":"crossref","unstructured":"Samantha\u00a0Cruz Rivera Xiaoxuan Liu An-Wen Chan Alastair\u00a0K. Denniston Melanie\u00a0Jane Calvert Hutan Ashrafian Andrew Beam Gary\u00a0S. Collins Ara Darzi Jonathan\u00a0J. Deeks Mohammed\u00a0K. Elzarrad Cyrus Espinoza Andre Esteva Livia Faes Lavinia\u00a0Ferrante di Ruffano J Fletcher Robert\u00a0M. Golub Hugh Harvey Charlotte\u00a0J Haug Christopher Holmes Adrian Jonas Pearse\u00a0A. Keane Christopher\u00a0J. Kelly Aaron\u00a0Y. Lee Cecilia\u00a0S. Lee Elaine Manna James Matcham Melissa\u00a0D. McCradden David Moher Joao Monteiro Cynthia\u00a0D. Mulrow Luke Oakden-Rayner Dina\u00a0N. Paltoo Maria\u00a0Beatrice Panico Gary Price Samuel d. Rowley Richard Savage Rupa Sarkar Sebastian\u00a0J. Vollmer and Christopher Yau. 2020. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. The BMJ 370(2020).","DOI":"10.1016\/S2589-7500(20)30219-3"},{"key":"e_1_3_2_1_206_1","unstructured":"D. Robertson K.\u00a0M. Lee Boryana\u00a0C. Lopez-Kolkovska and S. Villar. 2020. Response-adaptive randomization in clinical trials: from myths to practical considerations. arXiv: Methodology (2020)."},{"key":"e_1_3_2_1_207_1","doi-asserted-by":"crossref","unstructured":"David\u00a0S Robertson Babak Choodari-Oskooei Munya Dimairo Laura Flight Philip Pallmann and Thomas Jaki. 2021. Point estimation for adaptive trial designs. arXiv preprint arXiv:2105.08836(2021).","DOI":"10.1002\/sim.9605"},{"key":"e_1_3_2_1_208_1","volume-title":"Randomization in clinical trials: theory and practice","author":"Rosenberger F","unstructured":"William\u00a0F Rosenberger and John\u00a0M Lachin. 2015. Randomization in clinical trials: theory and practice. John Wiley & Sons."},{"key":"e_1_3_2_1_209_1","volume-title":"Randomization: The forgotten component of the randomized clinical trial. Statistics in medicine 38, 1","author":"Rosenberger F","year":"2019","unstructured":"William\u00a0F Rosenberger, Diane Uschner, and Yanying Wang. 2019. Randomization: The forgotten component of the randomized clinical trial. Statistics in medicine 38, 1 (2019), 1\u201312."},{"key":"e_1_3_2_1_210_1","doi-asserted-by":"crossref","unstructured":"Peter\u00a0M. Rothwell. 1995. Can overall results of clinical trials be applied to all patients?The Lancet 345(1995) 1616\u20131619.","DOI":"10.1016\/S0140-6736(95)90120-5"},{"key":"e_1_3_2_1_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70156-2"},{"key":"e_1_3_2_1_212_1","doi-asserted-by":"crossref","unstructured":"Richard\u00a0M. Royall Robert\u00a0H. Bartlett Richard\u00a0G. Cornell David\u00a0P. Byar William\u00a0D. Dupont Robert\u00a0J. Levine Foster Lindley R\u00a0John Simes and Marvin Zelen. 1991. Ethics and statistics in randomized clinical trials.Statistical science : a review journal of the Institute of Mathematical Statistics 6 1(1991) 52\u201388.","DOI":"10.1214\/ss\/1177011935"},{"key":"e_1_3_2_1_213_1","volume-title":"Pregnant People\u2019s Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.JAMA","author":"Rubin Rita","year":"2021","unstructured":"Rita Rubin. 2021. Pregnant People\u2019s Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.JAMA (2021)."},{"key":"e_1_3_2_1_214_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181653d58"},{"key":"e_1_3_2_1_215_1","volume-title":"Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.Pulmonary pharmacology & therapeutics 27 2","author":"Saturni Sara","year":"2014","unstructured":"Sara Saturni, Federico Bellini, Fulvio Braido, Pierluigi Paggiaro, Alessandro Sanduzzi, Nicola Scichilone, Pierachille Santus, Luca Morandi, and Alberto Papi. 2014. Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.Pulmonary pharmacology & therapeutics 27 2 (2014), 129\u201338."},{"key":"e_1_3_2_1_216_1","doi-asserted-by":"publisher","DOI":"10.1111\/bioe.12084"},{"key":"e_1_3_2_1_217_1","doi-asserted-by":"crossref","unstructured":"K. Schulman J. Berlin W. Harless J. Kerner S. Sistrunk B. Gersh R. Dub\u00e9 C.\u00a0K. Taleghani J.\u00a0E. Burke S. Williams J. Eisenberg and J. Escarce. 1999. The effect of race and sex on physicians\u2019 recommendations for cardiac catheterization.The New England journal of medicine 340 8 (1999) 618\u201326.","DOI":"10.1056\/NEJM199902253400806"},{"key":"e_1_3_2_1_218_1","volume-title":"The Origins and Emergence of Zika Virus, the Newest TORCH Infection: What\u2019s Old Is New Again.Archives of pathology & laboratory medicine 141 1","author":"Schwartz A.","year":"2017","unstructured":"David\u00a0A. Schwartz. 2017. The Origins and Emergence of Zika Virus, the Newest TORCH Infection: What\u2019s Old Is New Again.Archives of pathology & laboratory medicine 141 1 (2017), 18\u201325."},{"key":"e_1_3_2_1_219_1","doi-asserted-by":"crossref","unstructured":"David\u00a0A. Schwartz. 2018. Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation. Vaccines 6(2018).","DOI":"10.3390\/vaccines6040081"},{"key":"e_1_3_2_1_220_1","doi-asserted-by":"publisher","DOI":"10.1145\/3287560.3287598"},{"key":"e_1_3_2_1_221_1","volume-title":"Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. Annals of the New York Academy of Sciences 1387","author":"Sen Anando","year":"2017","unstructured":"Anando Sen, Patrick\u00a0B. Ryan, Andrew Goldstein, Shreya Chakrabarti, Shuang Wang, Eileen Koski, and Chunhua Weng. 2017. Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. Annals of the New York Academy of Sciences 1387 (2017)."},{"key":"e_1_3_2_1_222_1","volume-title":"Seven myths of randomisation in clinical trials.Statistics in medicine 32 9","author":"Senn J","year":"2013","unstructured":"Stephen\u00a0J Senn. 2013. Seven myths of randomisation in clinical trials.Statistics in medicine 32 9 (2013), 1439\u201350."},{"key":"e_1_3_2_1_223_1","doi-asserted-by":"publisher","DOI":"10.2190\/5FGJ-03AQ-BKW2-GLAA"},{"key":"e_1_3_2_1_224_1","volume-title":"International Conference on Machine Learning. PMLR, 8730\u20138740","author":"Shen Cong","year":"2020","unstructured":"Cong Shen, Zhiyang Wang, Sofia Villar, and Mihaela Van Der\u00a0Schaar. 2020. Learning for dose allocation in adaptive clinical trials with safety constraints. In International Conference on Machine Learning. PMLR, 8730\u20138740."},{"key":"e_1_3_2_1_225_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520180097047"},{"key":"e_1_3_2_1_226_1","volume-title":"Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization. Statistics & probability letters 81, 7","author":"Simon Richard","year":"2011","unstructured":"Richard Simon and Noah\u00a0Robin Simon. 2011. Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization. Statistics & probability letters 81, 7 (2011), 767\u2013772."},{"key":"e_1_3_2_1_227_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2029240"},{"key":"e_1_3_2_1_228_1","volume-title":"Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review.Drug discovery today 24 7","author":"Soekhai Vikas","year":"2019","unstructured":"Vikas Soekhai, Chiara Whichello, Bennett Levitan, Jorien Veldwijk, Cathy\u00a0Anne Pinto, Bas Donkers, Isabelle Huys, Eline van Overbeeke, Juhaeri Juhaeri, and Esther\u00a0W. de Bekker-Grob. 2019. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review.Drug discovery today 24 7 (2019), 1324\u20131331."},{"key":"e_1_3_2_1_229_1","doi-asserted-by":"crossref","unstructured":"Harriette G. C.\u00a0Van Spall Andrew Toren Alex Kiss and R.\u00a0A. Fowler. 2007. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.JAMA 297 11(2007) 1233\u201340.","DOI":"10.1001\/jama.297.11.1233"},{"key":"e_1_3_2_1_230_1","volume-title":"Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?Journal of comparative effectiveness research 8 5","author":"Sparano Francesco","year":"2019","unstructured":"Francesco Sparano, Neil\u00a0K. Aaronson, Francesco Cottone, Alfonso Piciocchi, Edoardo\u00a0La Sala, Am\u00e9lie Anota, Nina Deliu, Jacobien\u00a0M Kieffer, and Fabio Efficace. 2019. Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?Journal of comparative effectiveness research 8 5 (2019), 279\u2013288."},{"key":"e_1_3_2_1_231_1","volume-title":"Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.American heart journal 169 1","author":"Stafinski Tania","year":"2015","unstructured":"Tania Stafinski, Devidas Menon, Alexa\u00a0A Nardelli, Jeffrey\u00a0A Bakal, Justin\u00a0A. Ezekowitz, Wayne Tymchak, Robert\u00a0C. Welsh, Gabor\u00a0T. Gyenes, and Paul\u00a0W. Armstrong. 2015. Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.American heart journal 169 1 (2015), 122\u201331.e22."},{"key":"e_1_3_2_1_232_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2020.1790415"},{"key":"e_1_3_2_1_233_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.594945"},{"key":"e_1_3_2_1_234_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.183.6.01831539"},{"key":"e_1_3_2_1_235_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2003.tb00065.x"},{"key":"e_1_3_2_1_236_1","volume-title":"Subgroup Analysis via Recursive Partitioning. Econometrics: Single Equation Models eJournal","author":"Su Xiaogang","year":"2009","unstructured":"Xiaogang Su, Chih-Ling Tsai, Hansheng Wang, David\u00a0M. Nickerson, and Bogong Li. 2009. Subgroup Analysis via Recursive Partitioning. Econometrics: Single Equation Models eJournal (2009)."},{"key":"e_1_3_2_1_237_1","doi-asserted-by":"crossref","unstructured":"Oleksandr Sverdlov Yevgen Ryeznik and Weng\u00a0Kee Wong. 2021. Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools with examples from the cardiovascular field.Contemporary clinical trials(2021) 106397.","DOI":"10.1016\/j.cct.2021.106397"},{"key":"e_1_3_2_1_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30484-8"},{"key":"e_1_3_2_1_239_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2441"},{"key":"e_1_3_2_1_240_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/25.3-4.285"},{"key":"e_1_3_2_1_241_1","volume-title":"Clinical trials as treatment option: bioethics and health care disparities in substance dependency.Social science & medicine 69 12","author":"Timmermans Stefan","year":"2009","unstructured":"Stefan Timmermans and Tara McKay. 2009. Clinical trials as treatment option: bioethics and health care disparities in substance dependency.Social science & medicine 69 12 (2009), 1784\u201390."},{"key":"e_1_3_2_1_242_1","volume-title":"COM(2020) 65 final (the \u2019AI White Paper\u2019). ISN: Other Legal Perspectives in Information Systems (Topic)","author":"Tiple Vasile","year":"2020","unstructured":"Vasile Tiple. 2020. Recommendations on the European Commission\u2019s WHITE PAPER on Artificial Intelligence - A European approach to excellence and trust, COM(2020) 65 final (the \u2019AI White Paper\u2019). ISN: Other Legal Perspectives in Information Systems (Topic) (2020)."},{"key":"e_1_3_2_1_243_1","volume-title":"Torgerson and Bonnie Sibbald","author":"J.","year":"1998","unstructured":"David\u00a0J. Torgerson and Bonnie Sibbald. 1998. Understanding controlled trials: What is a patient preference trial?BMJ 316(1998), 360."},{"key":"e_1_3_2_1_244_1","unstructured":"RJ Turner A Ly and PD Gr\u00fcnwald. 2021. Two-sample tests that are safe under optional stopping. (2021)."},{"key":"e_1_3_2_1_245_1","volume-title":"American Society of Clinical Oncology. Annual Meeting 35","author":"Unger M.","year":"2016","unstructured":"Joseph\u00a0M. Unger, Elise\u00a0D. Cook, Eric\u00a0W Tai, and Archie Bleyer. 2016. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 35 (2016), 185\u201398."},{"key":"e_1_3_2_1_246_1","doi-asserted-by":"crossref","unstructured":"Joseph\u00a0M. Unger Riha Vaidya Kathy\u00a0S Albain Michael\u00a0L. Leblanc Lori\u00a0M. Minasian Carolyn Gotay N.\u00a0Lynn Henry Michael\u00a0J Fisch Shing\u00a0M. Lee Charles\u00a0D Blanke and Dawn\u00a0L. Hershman. 2022. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy Targeted Therapy or Chemotherapy in Cancer Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology(2022) JCO2102377.","DOI":"10.1200\/JCO.21.02377"},{"key":"e_1_3_2_1_247_1","unstructured":"Berk Ustun Yang Liu and David\u00a0C. Parkes. 2019. Fairness without Harm: Decoupled Classifiers with Preference Guarantees. In ICML."},{"key":"e_1_3_2_1_248_1","volume-title":"\u00a0M. van Delden","author":"van\u00a0der Graaf Rieke","year":"2012","unstructured":"Rieke van\u00a0der Graaf, Kit C.\u00a0B. Roes, and Johannes J.\u00a0M. van Delden. 2012. Adaptive trials in clinical research: scientific and ethical issues to consider.JAMA 307 22(2012), 2379\u201380."},{"key":"e_1_3_2_1_249_1","volume-title":"What matters to me \u2013 a web-based preference elicitation tool for clients in long-term care: a user-centred design. BMC Medical Informatics and Decision Making 20","author":"van Leersum M","year":"2020","unstructured":"Catharina\u00a0M van Leersum, Albine Moser, Ben van Steenkiste, Marion Reinartz, Esther Stoffers, Judith\u00a0R Wolf, and Trudy van\u00a0der Weijden. 2020. What matters to me \u2013 a web-based preference elicitation tool for clients in long-term care: a user-centred design. BMC Medical Informatics and Decision Making 20 (2020)."},{"key":"e_1_3_2_1_250_1","volume-title":"J\u00fcrgen K\u00fcbler, Juhaeri Juhaeri, Bennett Levitan, Esther\u00a0W. de Bekker-Grob, Jorien Veldwijk, and Isabelle Huys.","author":"van Overbeeke Eline","year":"2019","unstructured":"Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, Karin\u00a0Sch\u00f6lin Bywall, Jenny Sharpe, Nikoletta Nikolenko, Berkeley\u00a0S. Phillips, Paolo Guiddi, Gabriella Pravettoni, Laura Vergani, Giulia Marton, Irina Cleemput, Steven R\u00a0A Simoens, J\u00fcrgen K\u00fcbler, Juhaeri Juhaeri, Bennett Levitan, Esther\u00a0W. de Bekker-Grob, Jorien Veldwijk, and Isabelle Huys. 2019. Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study. Frontiers in Pharmacology 10 (2019)."},{"key":"e_1_3_2_1_251_1","volume-title":"The effect of patient race and socio-economic status on physicians","author":"van Ryn Michelle","year":"2000","unstructured":"Michelle van Ryn and Julia Burke. 2000. The effect of patient race and socio-economic status on physicians\u2019 perceptions of patients.Social science & medicine 50 6 (2000), 813\u201328."},{"key":"e_1_3_2_1_252_1","unstructured":"Yogatheesan Varatharajah Brent\u00a0M. Berry Oluwasanmi Koyejo and Ravishankar\u00a0Krishnan Iyer. 2018. A Contextual-bandit-based Approach for Informed Decision-making in Clinical Trials. ArXiv abs\/1809.00258(2018)."},{"key":"e_1_3_2_1_253_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2017.12.017"},{"key":"e_1_3_2_1_254_1","volume-title":"Using supervised machine learning classifiers to estimate likelihood of participating in clinical trials of a de-identified version of ResearchMatch. Journal of Clinical and Translational Science 5","author":"Vazquez Janette","year":"2020","unstructured":"Janette Vazquez, Samir\u00a0E. Abdelrahman, Loretta\u00a0M. Byrne, Michael Russell, Paul\u00a0A. Harris, and Julio\u00a0C. Facelli. 2020. Using supervised machine learning classifiers to estimate likelihood of participating in clinical trials of a de-identified version of ResearchMatch. Journal of Clinical and Translational Science 5 (2020)."},{"key":"e_1_3_2_1_255_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.1050"},{"key":"e_1_3_2_1_256_1","doi-asserted-by":"crossref","unstructured":"S. Villar J. Bowden and J. Wason. 2015. Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges.Statistical science : a review journal of the Institute of Mathematical Statistics 30 2(2015) 199\u2013215.","DOI":"10.1214\/14-STS504"},{"key":"e_1_3_2_1_257_1","volume-title":"Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?Pharmaceutical statistics 17, 2","author":"Villar S","year":"2018","unstructured":"Sof\u00eda\u00a0S Villar, Jack Bowden, and James Wason. 2018. Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?Pharmaceutical statistics 17, 2 (2018), 182\u2013197."},{"key":"e_1_3_2_1_258_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1027"},{"key":"e_1_3_2_1_259_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-16-S2-P232"},{"key":"e_1_3_2_1_260_1","doi-asserted-by":"crossref","unstructured":"Sof\u00eda\u00a0S. Villar James M.\u00a0S. Wason and Jack Bowden. 2015. Response-adaptive randomization for multi-arm clinical trials using the forward looking Gittins index rule.Biometrics 71 4(2015) 969\u201378.","DOI":"10.1111\/biom.12337"},{"key":"e_1_3_2_1_261_1","volume-title":"Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.The New England journal of medicine 383 9","author":"Vyas A","year":"2020","unstructured":"Darshali\u00a0A Vyas, L. Eisenstein, and David\u00a0S Jones. 2020. Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.The New England journal of medicine 383 9 (2020), 874\u2013882."},{"key":"e_1_3_2_1_262_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2017.1319839"},{"key":"e_1_3_2_1_263_1","doi-asserted-by":"crossref","unstructured":"Karin\u00a0A Wasmann Pieta\u00a0C Wijsman Susan van Dieren Willem\u00a0A Bemelman and Christianne Buskens. 2019. Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses. BMJ Open 9(2019).","DOI":"10.1136\/bmjopen-2019-031151"},{"key":"e_1_3_2_1_264_1","doi-asserted-by":"crossref","unstructured":"James\u00a0A. Watson and Chris\u00a0C. Holmes. 2020. Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error. Trials 21(2020).","DOI":"10.1186\/s13063-020-4076-y"},{"key":"e_1_3_2_1_265_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocx071"},{"key":"e_1_3_2_1_266_1","volume-title":"Generalizability of the results of randomized trials.Archives of internal medicine 168 2","author":"Weiss S","year":"2008","unstructured":"Noel\u00a0S Weiss, Thomas\u00a0D. Koepsell, and Bruce\u00a0M. Psaty. 2008. Generalizability of the results of randomized trials.Archives of internal medicine 168 2 (2008), 133\u20135."},{"key":"e_1_3_2_1_267_1","doi-asserted-by":"crossref","unstructured":"E.\u00a0Hope Weissler Tristan Naumann Tomas Andersson Rajesh Ranganath Olivier Elemento Yuan Luo Daniel\u00a0F. Freitag James Benoit Michael\u00a0C. Hughes Faisal Khan Paul Slater Khader Shameer Matthew Roe Emmette\u00a0R. Hutchison Scott\u00a0H. Kollins Uli\u00a0C. Broedl Zhaoling Meng Jennifer\u00a0L. Wong Lesley Curtis Erich\u00a0S Huang and Marzyeh Ghassemi. 2021. The role of machine learning in clinical research: transforming the future of evidence generation. Trials 22(2021).","DOI":"10.1186\/s13063-021-05571-4"},{"key":"e_1_3_2_1_268_1","doi-asserted-by":"crossref","unstructured":"David Wendler Raynard\u00a0S. Kington Jennifer\u00a0H. Madans Gretchen\u00a0Van Wye Heidi Christ-schmidt Laura\u00a0A. Pratt Otis\u00a0W Brawley Cary\u00a0P. Gross and Ezekiel\u00a0J. Emanuel. 2006. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?PLoS Medicine 3(2006).","DOI":"10.1371\/journal.pmed.0030019"},{"key":"e_1_3_2_1_269_1","volume-title":"How to design a dose-finding study using the continual reassessment method. BMC medical research methodology 19, 1","author":"Wheeler M","year":"2019","unstructured":"Graham\u00a0M Wheeler, Adrian\u00a0P Mander, Alun Bedding, Kristian Brock, Victoria Cornelius, Andrew\u00a0P Grieve, Thomas Jaki, Sharon\u00a0B Love, Lang\u2019o Odondi, Christopher\u00a0J Weir, 2019. How to design a dose-finding study using the continual reassessment method. BMC medical research methodology 19, 1 (2019), 1\u201315."},{"key":"e_1_3_2_1_270_1","doi-asserted-by":"crossref","unstructured":"J. Wiens S. Saria Mark\u00a0P. Sendak M. Ghassemi V. Liu Finale Doshi-Velez K. Jung K. Heller David\u00a0C. Kale Mohammed Saeed P. Ossorio Sonoo Thadaney-Israni and A. Goldenberg. 2019. Do no harm: a roadmap for responsible machine learning for health care. Nature Medicine (2019) 1\u20134.","DOI":"10.1038\/s41591-019-0609-x"},{"key":"e_1_3_2_1_271_1","first-page":"555","article-title":"Racial Bias in Health Care and Health","volume":"314","author":"Williams R","year":"2015","unstructured":"David\u00a0R Williams and R. Wyatt. 2015. Racial Bias in Health Care and Health: Challenges and Opportunities.JAMA 314 6(2015), 555\u20136.","journal-title":"Challenges and Opportunities.JAMA"},{"key":"e_1_3_2_1_272_1","unstructured":"J.\u00a0J. Williams Jacob Nogas N. Deliu Hammad Shaikh S. Villar Audrey Durand and Anna\u00a0N. Rafferty. 2021. Challenges in Statistical Analysis of Data Collected by a Bandit Algorithm: An Empirical Exploration in Applications to Adaptively Randomized Experiments. ArXiv abs\/2103.12198(2021)."},{"key":"e_1_3_2_1_273_1","doi-asserted-by":"crossref","unstructured":"S. Williamson P. Jacko S. Villar and T. Jaki. 2017. A Bayesian adaptive design for clinical trials in rare diseases. Computational statistics & data analysis 113 (2017) 136 \u2013 153.","DOI":"10.1016\/j.csda.2016.09.006"},{"key":"e_1_3_2_1_274_1","volume-title":"Patients","author":"Woloshin K\u00a0K","year":"1994","unstructured":"K\u00a0K Woloshin, Mack\u00a0T. Ruffin, and Daniel\u00a0W. Gorenflo. 1994. Patients\u2019 interpretation of qualitative probability statements.Archives of family medicine 3 11 (1994), 961\u20136."},{"key":"e_1_3_2_1_275_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-02871-3"},{"key":"e_1_3_2_1_276_1","volume-title":"A unified framework for bandit multiple testing. Advances in Neural Information Processing Systems 34","author":"Xu Ziyu","year":"2021","unstructured":"Ziyu Xu, Ruodu Wang, and Aaditya Ramdas. 2021. A unified framework for bandit multiple testing. Advances in Neural Information Processing Systems 34 (2021)."},{"key":"e_1_3_2_1_277_1","unstructured":"Fanny Yang Aaditya Ramdas Kevin Jamieson and Martin\u00a0J Wainwright. 2017. A framework for Multi-A (rmed)\/B (andit) Testing with Online FDR Control. arXiv preprint arXiv:1706.05378(2017)."},{"key":"e_1_3_2_1_278_1","volume-title":"Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Science translational medicine 11, 473","author":"Yang Wei","year":"2019","unstructured":"Wei Yang, Nicole\u00a0M Warrington, Sara\u00a0J Taylor, Paula Whitmire, Eduardo Carrasco, Kyle\u00a0W Singleton, Ningying Wu, Justin\u00a0D Lathia, Michael\u00a0E Berens, Albert\u00a0H Kim, 2019. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Science translational medicine 11, 473 (2019)."},{"key":"e_1_3_2_1_279_1","volume-title":"Play the winner for phase II\/III clinical trials. Statistics in medicine 15, 22","author":"Yao Q","year":"1996","unstructured":"Q Yao and LJ Wei. 1996. Play the winner for phase II\/III clinical trials. Statistics in medicine 15, 22 (1996), 2413\u20132423."},{"key":"e_1_3_2_1_280_1","doi-asserted-by":"publisher","DOI":"10.1145\/3038912.3052660"},{"key":"e_1_3_2_1_281_1","volume-title":"Fairness Constraints: Mechanisms for Fair Classification. In AISTATS.","author":"Zafar B.","year":"2017","unstructured":"M.\u00a0B. Zafar, Isabel Valera, M. Gomez-Rodriguez, and K. Gummadi. 2017. Fairness Constraints: Mechanisms for Fair Classification. In AISTATS."},{"key":"e_1_3_2_1_282_1","doi-asserted-by":"publisher","DOI":"10.5555\/3322706.3362016"},{"key":"e_1_3_2_1_283_1","unstructured":"Muhammad\u00a0Bilal Zafar Isabel Valera Manuel Gomez-Rodriguez Krishna\u00a0P. Gummadi and Adrian Weller. 2017. From Parity to Preference-based Notions of Fairness in Classification. In NIPS."},{"key":"e_1_3_2_1_284_1","unstructured":"R. Zemel Ledell\u00a0Yu Wu Kevin Swersky T. Pitassi and C. Dwork. 2013. Learning Fair Representations. In ICML."},{"key":"e_1_3_2_1_285_1","doi-asserted-by":"publisher","DOI":"10.1145\/3278721.3278779"},{"key":"e_1_3_2_1_286_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocw176"},{"key":"e_1_3_2_1_287_1","doi-asserted-by":"crossref","unstructured":"Xingyao Zhang Cao Xiao Lucas Glass and Jimeng Sun. 2020. DeepEnroll: Patient-Trial Matching with Deep Embedding and Entailment Prediction. ArXiv abs\/2001.08179(2020).","DOI":"10.1145\/3366423.3380181"},{"key":"e_1_3_2_1_288_1","volume-title":"China: a retrospective cohort study. The lancet 395, 10229","author":"Zhou Fei","year":"2020","unstructured":"Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu, 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet 395, 10229 (2020), 1054\u20131062."},{"key":"e_1_3_2_1_289_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0494-6"},{"key":"e_1_3_2_1_290_1","volume-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences 11","author":"Zucker Irving","year":"2020","unstructured":"Irving Zucker and Brian\u00a0J. Prendergast. 2020. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences 11 (2020)."}],"event":{"name":"FAccT '22: 2022 ACM Conference on Fairness, Accountability, and Transparency","location":"Seoul Republic of Korea","acronym":"FAccT '22","sponsor":["ACM Association for Computing Machinery"]},"container-title":["2022 ACM Conference on Fairness Accountability and Transparency"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3531146.3533154","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3531146.3533154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T19:02:08Z","timestamp":1750186928000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3531146.3533154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":289,"alternative-id":["10.1145\/3531146.3533154","10.1145\/3531146"],"URL":"https:\/\/doi.org\/10.1145\/3531146.3533154","relation":{},"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"2022-06-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}